Author

Brian J. Sworder

Stanford MedicineORCID 0000-0002-5902-5507Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Ash A. AlizadehiD· 2 shared Alan B CooperiD· 1 shared Alexander BagaeviD· 1 shared Allison Barz LeahyiD· 1 shared Astraea Jager· 1 shared Benedikt W. PelzeriD· 1 shared Bita SahafiD· 1 shared Bonnie YatesiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ash A. AlizadehORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedApr 23, 2025

IKAROS facilitates antigen escape in the face of CD19- and CD22-targeted therapies for B-cell acute lymphoblastic leukemia

Pablo Domizi, Jolanda Sarno, Astraea Jager…·Kara Lynn Davis

This study identifies IKAROS as a factor associated with antigen escape in B-ALL, showing that low IKAROS levels lead to reduced B-cell antigen expression and resistance to CD19- and CD22-targeted therapies.

22 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedJan 27, 2025

Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma

Sravya Tumuluru, James K. Godfrey, Alan B Cooper…·Justin Paul Kline

This study identifies unique immune environments in DLBCL associated with response to immunotherapy using an integrative multi-omic approach.

35 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky